The clinical study and HLA genotyping of 112 familial myasthenia gravis patients

Abstract

One hundred and twelve cases of familial myasthenia gravis (MG) from 44 families selected from 2100 patients with MG diagnosed since 1983 in the Department of Neurology were studied. The clinical pictures and immunological features of the patients showed a great resemblance to those of sporadic cases. The pedigree analysis disclosed that the hereditary patterns of familial patients were basically Mendellian autosomal inheritance. Many predisposing factors such as fever, infection, use of aminoglycoside or vaccines, played an important role in presenting the phenotype of subclinical cases. The HLA genotyping suggested that the complement polymorphism C4A * 4, the complotype S42, and the genes 0901 and 1301 of DRB1 allele, were related to the pathogenesis of MG. It was concluded that the phenotype of MG may be the result of interaction between hereditary defects and environmental factors.

Keywords

familial myasthenia gravis / Mendellian autosomal inheritance / HLA genotyping / pedigree analysis

References

[1] BergoffenJ, ZmijewskiC M, FischbeckK H. Familial autoimmune myasthenia gravis. Neurology, 1994, 44: 551-551

[2] CelesiaG G. Myasthenia gravis in two siblings. Arch Neurol, 1965, 12: 206-206

[3] FoldesF F, McNallP G. Unusual familial occurrence of myasthenia gravis. JAMA, 1960, 174: 418-418

[4] HermannC. Myasthenia gravis occuring in families. Neurology, 1966, 16: 75-75

[5] TheileU, KesslerS. Effect of heredity and environment in immune diseases. Presentation of twin data. Med Klin, 1994, 15: 312-312

[6] MurphyJ, MurphyS F. Myasthenia gravis in identical twins. Neurology, 1986, 36(1): 78-78

[7] ChristodoulouK, TsingisM, DeymeerF, et al. . Mapping of the familial infantile myasthenia gravis (congenital myasthenic syndrome type la) gene to chromosome 17p with evidence of genetic homogeneity. Hum Molec Genet, 1997, 6: 635-635

[8] EhgelA G, LambertE H, GomezM R. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol, 1977, 1: 315-315

[9] DjabiriF, Caillat-ZucmauS, GajdosP. Association of the AchRalpha-subunit gene (CHRNA), DQA1 * 0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. J Autoimmune, 1997, 10(4): 407-407

[10] HuntJ M, BommertK, CharltonM P, et al. . A post-docking role for synaptobrevin in synaptic vesicle fusion. Neuron, 1994, 12: 1269-1269

[11] TolaM R, CaniattiL M, CasettaI, et al. . Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy. Acta Neurol Scand, 1994, 90: 318-318

[12] NalaoY, MatsumotoH, MiyazakiT. Gm allotypes in myasthenia gravis. Lancet, 1980, I: 677-677

[13] HLA-DRB1 1995, 21(1):18

[14] HLA-I 1991, 7(3):156